The First Affiliated Hospital/School of Clinical Medicine of Guangdong Pharmaceutical University
The First Affiliated Hospital/School of Clinical Medicine of Guangdong Pharmaceutical University
Guangzhou, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tislelizumab Combined with Mitoxantrone Hydrochloride Liposome in Extranodal Natural Killer/T Cell Lymphoma | Extranodal Natural Killer T Cell Lymphoma | Active, not recruiting | Phase 1 / Phase 2 | 2025-03-13 | NCT05464433 |